Rainer Sigl

Title: Rainer Sigl: Innovator in Pharmaceutical Formulations

Introduction

Rainer Sigl is a notable inventor based in Puchheim, Germany. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of liquid compositions for medical applications. With a total of five patents to his name, Sigl's work focuses on innovative solutions for treating eye diseases.

Latest Patents

Among his latest patents is a liquid formulation of a VEGF antagonist. This invention relates to liquid pharmaceutical compositions designed for intravitreal administration, which include a histidine buffer, an inorganic salt, a carbohydrate, and a polysorbate. Another significant patent is for a pharmaceutical composition of an anti-VEGF antibody. This formulation is intended for intravitreal injection and notably does not contain saccharides, making it suitable for the treatment of age-related macular degeneration.

Career Highlights

Rainer Sigl has worked with several companies throughout his career, including Scil Technology GmbH and Formycon AG. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.

Collaborations

Some of his notable coworkers include Klaus Hellerbrand and Andreas Schuetz. Their collaboration has likely contributed to the advancements in the projects they have worked on together.

Conclusion

Rainer Sigl's contributions to pharmaceutical formulations demonstrate his commitment to innovation in the medical field. His patents reflect a deep understanding of the complexities involved in developing effective treatments for serious conditions.